Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
2026-08-28
|
5-day change | 1st Jan Change | ||
| 190,700.00 KRW | -0.31% |
|
-1.75% | +10.63% |
| Aug. 25 | Celltrion Launches Omlyclo 300 Mg Strength In Key European Markets | CI |
| Aug. 23 | Celltrion Submits Marketing Application for Keytruda Biosimilar in South Korea | MT |
| Market Cap | 45,768B 33.27B 28.74B 26.91B 24.62B 46.27B 3,173B 46.45B 319B 125B 1,605B 125B 122B 5,339B | P/E 2026 * |
29x | P/E 2027 * | 25.1x |
|---|---|---|---|---|---|
| Enterprise Value | 47.97B 34.87M 30.12M 28.2M 25.81M 48.49M 3.32B 48.69M 335M 131M 1.68B 131M 128M 5.6B | EV / Sales 2026 * |
8.75x | EV / Sales 2027 * | 7.5x |
| Free-Float |
60.59% | Yield 2026 * |
0.4% | Yield 2027 * | 0.43% |
| 1 day | -0.31% | ||
| 1 week | -1.75% | ||
| Current month | +2.14% | ||
| 1 month | +6.72% | ||
| 3 months | +2.95% | ||
| 6 months | -16.04% | ||
| Current year | +10.63% |
| 1 week | 187,600 |  | 196,800 |
| 1 month | 177,300 | | 212,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 50 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/16/26 | Sell | 500 | 0.0002% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | -1.75% | +17.23% | +52.37% | 33.23B | |
| -0.78% | -0.34% | +1.99% | +23.35% | 51.14B | |
| -6.00% | -1.82% | +446.48% | +527.28% | 47.4B | |
| -0.24% | +2.23% | +38.64% | +19.52% | 43.19B | |
| -1.55% | -0.66% | +22.19% | +84.83% | 42.35B | |
| -1.79% | -1.96% | +26.86% | +131.18% | 17.07B | |
| -0.58% | -2.71% | - | - | 16.38B | |
| -0.88% | -0.63% | +11.05% | +29.54% | 14.76B | |
| -1.66% | +0.02% | +79.05% | +45.47% | 14.15B | |
| +0.18% | -2.44% | -2.29% | -33.67% | 13.09B | |
| Average | -0.71% | +0.36% | +71.24% | +97.76% | 29.28B | |
| Weighted average by Cap. | -0.60% | +0.95% | +94.64% | +127.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,480B 3.98B 3.44B 3.22B 2.95B 5.54B 380B 5.56B 38.24B 14.93B 192B 14.96B 14.63B 639B | 6,294B 4.58B 3.95B 3.7B 3.39B 6.36B 436B 6.39B 43.92B 17.14B 221B 17.18B 16.8B 734B |
| Net income | 1,511B 1.1B 949M 888M 813M 1.53B 105B 1.53B 10.54B 4.12B 52.97B 4.12B 4.03B 176B | 1,763B 1.28B 1.11B 1.04B 949M 1.78B 122B 1.79B 12.3B 4.8B 61.82B 4.81B 4.71B 206B |
| Net Debt | 2,199B 1.6B 1.38B 1.29B 1.18B 2.22B 152B 2.23B 15.34B 5.99B 77.08B 6B 5.87B 256B | 1,409B 1.02B 885M 829M 758M 1.42B 97.67B 1.43B 9.83B 3.84B 49.4B 3.85B 3.76B 164B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | ₩190,700.00 | -0.31% | 375,920 |
| 26-08-27 | ₩191,300.00 | -1.09% | 255,697 |
| 26-08-26 | ₩193,400.00 | +2.00% | 326,386 |
| 26-08-25 | ₩189,600.00 | -2.27% | 358,412 |
| 26-08-24 | ₩194,000.00 | +0.88% | 314,860 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
